Blossom Health has raised $20 million in seed and Series A funding to bring an AI “copilot” for psychiatry to patients nationwide, Fortune has exclusively learned. The announcement comes as venture dollars have largely chased more generic AI plays, but as investors have increasingly begun to fund AI enabled health tech. The New York–based startup is positioning itself as an AI‑native psychiatry platform, arguing that the technology finally makes it possible to scale high‑quality mental health care without flooding clinics with more staff.
The round, led by Headline with participation from Village Global, TA Ventures, Operator Partners, and Correlation Ventures, also adds Headline cofounder Mathias Schilling to the board.
